E.R. Squibb, 1854

1854 journal belonging to E.R. Squibb, which includes his development of an ether-distilling process, as well as daily entries with descriptions of his laboratory work. A fire in 1858 in Squibb's laboratory damaged the journal.Otis Historical Archives, National Museum of Health and Medicine, AFIP, Photo: © Jason varney | Varneyphoto.com Before Edward R. Squibb (1819-1900) founded the drug company that bore his n

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Before Edward R. Squibb (1819-1900) founded the drug company that bore his name, he was a United States Navy doctor who was unimpressed by the quality of medicines available on ships. In 1854, he developed a method of safely distilling ether for use as an anesthetic. He did not patent his method, but instead published it freely. His daily journal, shown here, documented his experiments with ether and chloroform in Philadelphia.

On November 25, 1854, a typical day, he visited bookstores with famed naturalist Joseph Leidy, and then attended a medical lecture. Squibb noted: "Finally an amputation of the thigh in a middle-age woman. Done pretty well - with Ether." This operation, using the ether that made it successful, would be performed frequently in the following decade.

In 1858, the same year he founded E.R. Squibb, ether caused a disastrous fire in his laboratory; the fire burned both Squibb and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Michael Rhode

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours